Evidence map›Paper›PMID 29504531›Full record

ArticleJournal of Alzheimer's disease : JAD2018

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Morgane Cam, Emilie Durieu, Marion Bodin, Antigoni Manousopoulou, Svenja Koslowski, Natalia Vasylieva, Bogdan Barnych, Bruce D Hammock, Bettina Bohl, Philipp Koch and 19 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Long-Term Fipronil Treatment Induces Hyperactivity in Female Mice.International journal of environmental research and public health · 2020
    Article
  10. Fungicide Residues Exposure andEnvironmental health perspectives · 2020
    Article
  11. Neurotoxicity of pesticides.Acta neuropathologica · 2019
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 7 countries.

Morgane CamManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.
Emilie DurieuManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.
Marion BodinManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.
Antigoni ManousopoulouFaculty of Medicine, Cancer Sciences and Clinical and Experimental Medicine, University of Southampton, Southampton, UK.
Svenja KoslowskiManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.
Natalia VasylievaDepartment of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA.
Bogdan BarnychDepartment of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA.
Bruce D HammockDepartment of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA.
Bettina BohlInstitute of Reconstructive Neurobiology, University of Bonn, Bonn, Germany.
Philipp KochInstitute of Reconstructive Neurobiology, University of Bonn, Bonn, Germany.
Chiori OmoriLaboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Kazuo YamamotoDepartment of Integrated Bioscience, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan.
Saori HataLaboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Toshiharu SuzukiLaboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Frank KargHPC INTERNATIONAL SAS and Atlantis Développement SAS, Noyal-Châtillon sur Seiche, Saint-Erblon, France.
Patrick GizziPlate-forme TechMedILL, UMR 7242, ESBS - Pôle API, Illkirch cedex, France.
Vesna Erakovic HaberFidelta d.o.o., Zagreb, Croatia.
Vlatka Bencetic MihaljevicFidelta d.o.o., Zagreb, Croatia.
Branka TavcarFidelta d.o.o., Zagreb, Croatia.
Erik PorteliusClinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Josef PanneeClinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Kaj BlennowClinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Henrik ZetterbergClinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Spiros D GarbisFaculty of Medicine, Cancer Sciences and Clinical and Experimental Medicine, University of Southampton, Southampton, UK.
Pierrick AuvrayC.RIS Pharma, Parc Technopolitain, Atalante Saint Malo, Saint Malo, France.
Hermeto GerberFoundation Eclosion, Switzerland.
Jeremy FraeringFoundation Eclosion, Switzerland.
Patrick C FraeringFoundation Eclosion, Switzerland.
Laurent MeijerManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.
ManRos Therapeutics (France) · FRUniversity of California, Davis · USCentre Hospitalier de Saint-Malo · FRHokkaido University · JPThe University of Tokyo · JPUniversity of Gothenburg · SEUniversity of Southampton · GBHeidelberg University · DESahlgrenska University Hospital · SEUniversity College London · GBUniversity of Bonn · DEUniversity of Fribourg · CH

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Training and Education CoreU54NS079202 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEIN, PAMELA J · 2012 to 2021
$35.7M
HYDROLYTIC ENZYMES IN THE METABOLISM OF TOXINSR01ES002710 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1985 to 2018
$4.0M
NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R01 ES002710NINDS NIH HHS U54 NS079202
6 · The paper itself

Abstract

Generation of amyloid-β peptides (Aβs) by proteolytic cleavage of the amyloid-β protein precursor (AβPP), especially increased production of Aβ42/Aβ43 over Aβ40, and their aggregation as oligomers and plaques, represent a characteristic feature of Alzheimer's disease (AD). In familial AD (FAD), altered Aβ production originates from specific mutations of AβPP or presenilins 1/2 (PS1/PS2), the catalytic subunits of γ-secretase. In sporadic AD, the origin of altered production of Aβs remains unknown. We hypothesize that the 'human chemical exposome' contains products able to favor the production of Aβ42/Aβ43 over Aβ40 and shorter Aβs. To detect such products, we screened a library of 3500 + compounds in a cell-based assay for enhanced Aβ42/Aβ43 production. Nine pyrazole insecticides were found to induce a β- and γ-secretase-dependent, 3-10-fold increase in the production of extracellular Aβ42 in various cell lines and neurons differentiated from induced pluripotent stem cells derived from healthy and FAD patients. Immunoprecipitation/mass spectrometry analyses showed increased production of Aβs cleaved at positions 42/43, and reduced production of peptides cleaved at positions 38 and shorter. Strongly supporting a direct effect on γ-secretase activity, pyrazoles shifted the cleavage pattern of another γ-secretase substrate, alcadeinα, and shifted the cleavage of AβPP by highly purified γ-secretase toward Aβ42/Aβ43. Focusing on fipronil, we showed that some of its metabolites, in particular the persistent fipronil sulfone, also favor the production of Aβ42/Aβ43 in both cell-based and cell-free systems. Fipronil administered orally to mice and rats is known to be metabolized rapidly, mostly to fipronil sulfone, which stably accumulates in adipose tissue and brain. In conclusion, several widely used pyrazole insecticides enhance the production of toxic, aggregation prone Aβ42/Aβ43 peptides, suggesting the possible existence of environmental "Alzheimerogens" which may contribute to the initiation and propagation of the amyloidogenic process in sporadic AD.

Indexed as

Adipose TissueAlzheimer DiseaseAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAnimalsBrainEnvironmental ExposureHEK293 CellsHumansInduced Pluripotent Stem CellsInsecticidesMiceNeuronsPeptide FragmentsProteomePyrazolesAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)amyloid beta-protein (1-43)Amyloid Precursor Protein SecretasesInsecticidesPeptide FragmentsProteomePyrazolesaftinsalzheimerogenAlzheimer’s diseaseamyloid-βamyloid-β protein precursorAβ38Aβ40Aβ42Aβ42/Aβ40 ratioAβ43fipronilhuman chemical exposomepesticidesphenylpyrazolespreventionpyrazolestriazinesγ-secretase

Identifiers

PMID29504531
PMCPMC7065497
OpenAlexW2789040171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.